Trial Profile
A Clinical exploratory study of apatinib plus FOLFIRI as second-line treatment with advanced colorectal cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 29 Mar 2017 New trial record